CD4 and neoplasm: Tumor or tumor-associated cells actively and directly inhibit immune responses via secretion of immunosuppressive cytokines such as interleukin (IL)-10 [42] and transforming growth factor (TGF)-β1 [43,44], and by skewing CD4 T cell responses to TH2 rather than TH1 [45,46].